Teclistamab-cqyv
(UPDATE) Daratumumab
(UPDATE) Ixazomib
Elotuzumab
International Myeloma Foundation (IMF)
The Leukemia and Lymphoma Society
ASCO: COVID-19 Medical Resources
National Cancer Institute (NCI) - Supported Cancer Clinical Trials